For example, SMAD4 mutations are not typical of pancreatic intraductal papillary mucinous neoplasms but occur in up to 16% of invasive carcinomas that are associated with IPMN [16]. Here, SMAD4 is linked to pancreatic intraductal papillary-mucinous neoplasm.